In addition, topical propionate attenuates skin inflammation in the MC903-driven mouse model of AD by counteracting IL-33 production in keratinocytes through the inhibition of histone deacetylase and regulation of the aryl hydrocarbon receptor signalling pathway [177]. This evidence concerns the gene IL33 and Alzheimer disease.